These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [New steps towards an influenza A vaccine]. Nau JY. Rev Med Suisse; 2006 May 31; 2(68):1499. PubMed ID: 16783999 [No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC. Vaccine; 2008 Nov 25; 26(50):6383-91. PubMed ID: 18801398 [Abstract] [Full Text] [Related]
12. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J. Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216 [Abstract] [Full Text] [Related]
15. NEW technologies for meeting the global demand for pandemic influenza vaccines. Fedson DS. Biologicals; 2008 Nov 16; 36(6):346-9. PubMed ID: 18715803 [Abstract] [Full Text] [Related]
19. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E. Vaccine; 2009 Aug 27; 27(39):5393-401. PubMed ID: 19596415 [Abstract] [Full Text] [Related]